10.12.2020 • News

Axens, Cargill and IFPEN Link on Bio-Acrylic acid

French technology company Axens, its parent company IFP Energies nouvelles (IFPEN), and US food and agricultural giant Cargill are joining forces to further develop and scale bio-based acrylic acid.

The partners aim to commercialize lactic-to-acrylic-acid technology that Procter & Gamble has been developing in its laboratories and which it licensed to Cargill in May.

“By leveraging Cargill’s processing technology and IFPEN/Axens’ know-how in catalysis and scale up, we’re aiming to produce acrylic acid from renewable sources thereby reducing greenhouse gas emissions by more than 50 percent,” said Jill Zullo, vice president of bio-intermediates in Cargill’s bio-industrial business. She added that more than 6 million t of fossil-based acrylic acid will be produced this year.

Efforts will focus on the catalyst and process development needed to convert lactic acid into bio-based acrylic acid at scale. Acrylic acid is used in various applications, from hygiene products to household paints.

The companies will advance the technology according to staged milestones. Although it will be several years before it is ready to be deployed at commercial scale, they said test samples could be ready for potential customers sometime within the next 12 months. 

Author: Elaine Burridge, Freelance Journalist

Axens, IFP Energies nouvelles and Cargill are linking to further develop and...
Axens, IFP Energies nouvelles and Cargill are linking to further develop and scale bio-based acrylic acid. The partners aim to commercialize lactic-to-acrylic-acid technology that Procter & Gamble has been developing in its laboratories and which it licensed to Cargill in May. (c) PilMo Kang

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.